November 2019
Why Metrion’s CSO spent 35 years unlocking the potential of ion channels for drug discovery
Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special [...]
August 2019
Nav1.5(Late) Cardiac Safety Assay on QPatch
The Metrion Biosciences team have recently produced a second application note in collaboration with Sophion Bioscience, describing the use of a ∆KPQ LQT3 mutant to create and validate [...]
Opportunities for Ion Channel Targeting Antibodies: Current Landscape and Pipeline
Metrion Biosciences’ tenth External Speaker Series presentation featured Dr Catherine Hutchings, a highly experienced biologics drug discovery researcher and independent consultant. Dr Hutchings’ presentation included an overview of [...]
July 2019
An Interview with Professor Nikita Gamper
Professor Nikita Gamper, the ninth contributor to Metrion Biosciences External Speaker Series, gives a perspective below regarding his ion channel research focus and collaboration activities with scientists from [...]
ELRIG: Advances in Cell Based Screening – Gothenburg, Sweden
ELRIG is a not-for-profit organisation aiming to provide access to high level scientific content, promote innovation in drug discovery and provide networking platforms for the life science community. [...]